Article
Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
Journal of clinical immunology - 1 Aug 2020
Yang Jun, Zhu Guang-Hua, Wang Bin, Zhang Rui, Jia Chen-Guang, Yan Yan, Ma Hong-Hao, Qin Mao-Quan
Abstract excerpt
PURPOSE: X-linked inhibitor of apoptosis (XIAP) deficiency caused by mutations in the XIAP/BIRC4 gene is a rare inherited primary immunodeficiency also known as X-linked lymphoproliferative syndrome type 2 (XLP2). Hematopoietic stem cell transplantation (HSCT) is currently the only curative strategy available. However, few studies of haploidentical HSCT have been published regarding the outcomes in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
